InvestorsHub Logo
Followers 0
Posts 178
Boards Moderated 0
Alias Born 12/04/2013

Re: None

Tuesday, 08/08/2017 9:20:14 AM

Tuesday, August 08, 2017 9:20:14 AM

Post# of 8545
Q2 Results - the usual lower than expected royalties (is Shire actually selling HyQ as there seems precious little evidence that they are) - out of control expenses due to funding numerous PEG trials all at the same time - no new partners (again) - no HALO301 news despite promised interim updates - but at least we have the Roche milestone for Mabthera US approval to reduce the massive losses slightly. Business as usual then.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News